发明授权
US09441048B2 Antibody for 3′-isoLM1 and 3′,6′-iso-LD1 gangliosides
有权
3'-isoLM1和3',6'-iso-LD1神经节苷脂的抗体
- 专利标题: Antibody for 3′-isoLM1 and 3′,6′-iso-LD1 gangliosides
- 专利标题(中): 3'-isoLM1和3',6'-iso-LD1神经节苷脂的抗体
-
申请号: US13988696申请日: 2011-11-15
-
公开(公告)号: US09441048B2公开(公告)日: 2016-09-13
- 发明人: Darell Bigner , Chien-Tsun Kuan , Ira H. Pastan , Hailan Piao
- 申请人: Darell Bigner , Chien-Tsun Kuan , Ira H. Pastan , Hailan Piao
- 申请人地址: US DC Washington US NC Durham
- 专利权人: The United States of America as represented by the Secretary of Health and Human Services,Duke University
- 当前专利权人: The United States of America as represented by the Secretary of Health and Human Services,Duke University
- 当前专利权人地址: US DC Washington US NC Durham
- 代理机构: Banner & Witcoff, LTD
- 国际申请: PCT/US2011/060759 WO 20111115
- 国际公布: WO2012/071216 WO 20120531
- 主分类号: C07K16/30
- IPC分类号: C07K16/30 ; A61K51/10 ; A61K47/48 ; C07K16/44 ; A61K39/00
摘要:
High affinity antibodies were made to gangliosides expressed on tumor cells. The antibodies can be used analytically, diagnostically, therapeutically, and theranostically. The antibodies may be used to target cytotoxic reagents to tumor cells, thus minimizing full-body toxicity. The antibodies may also be used with out added cytotoxin. The antibodies may be detectably labeled or labelable for analytic and diagnostic purposes. The combination of specificity and affinity of the antibodies render them particularly useful.
公开/授权文献
- US20140010829A1 ANTIBODIES FOR TUMOR GANGLIOSIDES 公开/授权日:2014-01-09
信息查询